Bruker showcases new assays at ECCMIB 2022

By The Science Advisory Board staff writers

April 25, 2022 -- Bruker debuted new multiplex polymerase chain reaction (PCR) infectious disease assays and upgrades to its existing matrix-assisted laser desorption/ionization (MALDI) Biotyper platform at the annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMIB).

The FluoroType Mycobacteria PCR assay launches on the FluoroCycler XT thermocycler and uses the company's LiquidArray technology to differentiate 31 nontuberculous mycobacteria and the M. tuberculosis complex from cultures in a single test.

The FluoroType PCR assay for detecting sexually transmitted infections (STIs) also uses the LiquidArray technology; the assay detects nine targets from seven sexually transmitted pathogens using a single test. The assay detects two independent genes for both Neisseria gonorrhoea and Chlamydia trachomatis. The STI assay is validated on the GenoXtract extraction system and the Fluorocycler XT thermocycler.

Bruker also showcased its new MBT Compass HT in vitro diagnostics (IVD) software at ECCMIB 2022. The application provides higher sample throughput for the MALDI Biotyper with a system time-to-result of ~5 minutes for 96 sample spots. It identifies up to 600 samples/hour/instrument.

Finally, the firm announced it has added 393 new species to its IVD CE-labeled MALDI Biotyper Reference Libraries, providing nearly universal identification capabilities for 4,381 species.

None of the featured products are available for sale yet in the U.S.

Bruker acquires Optimal companies for pharma software, technologies
Bruker has acquired biopharma solutions provider Optimal Industrial Automation and Technologies. The company said that the acquisition will strengthen...
Bruker expands nanoflow consumables portfolio
Bruker Corporation has acquired PepSep, a company specializing in nanoflow liquid chromatography columns, specialty emitters, and components to optimize...
Bruker launches new timsTOF-based MALDI PharmaPulse system
Bruker Corporation has launched its trapped ion mobility spectronomy time-of-flight (timsTOF) matrix-assisted laser desorption/ionization (MALDI) PharmaPulse...
Bruker acquires Prolab Instruments
Bruker has acquired Prolab Instruments, a company that specializes in low-flow, high-precision liquid chromatography technology and systems. The acquisition...
Bruker touts multiomics platform at HUPO Reconnect 2021
Bruker touted advances in collision cross section-enabled 4D proteomics workflows on the trapped ion mobility spectrometry time-of-flight (timsTOF) multiomics...

Copyright © 2022

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter